Lomitapide and Estradiol: Interaction Details

Brand names
Lomitapide
Juxtapid
Estradiol
VivelleAloraMinivelle +13 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Estradiol

Brand names
  • Vivelle
  • Alora
  • Minivelle
  • Yuvafem
  • Imvexxy
  • Estrace
  • Depo-Estradiol
  • Delestrogen
  • Dotti
  • Lyllana
  • Divigel
  • Climara
  • Menostar
  • EstroGel
  • Elestrin
  • Evamist

What Happens When You Take Lomitapide With Estradiol

What can happen when they are taken together (rated Major)

Increased lomitapide exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Lomitapide is a , and oral contraceptives act as weak CYP3A4 , so giving them together may raise lomitapide exposure. When lomitapide is used with oral contraceptives, the maximum recommended dosage is 15 mg for ages 2 to 10 years, 30 mg for ages 11 to 17 years, and 40 mg for ages 18 years and older.

The schedule during of a weak CYP3A4 is as follows. For ages 2 to 10 years, the dose is 2 mg during weeks 0 to 8, 5 mg during weeks 9 to 12, 10 mg during weeks 13 to 16, and 20 mg from week 17 onward, and higher doses are not recommended.

For ages 11 to 15 years, titration starts at 2 mg (weeks 0 to 4), then moves to 5 mg (weeks 5 to 8), 10 mg (weeks 9 to 12), 20 mg (weeks 13 to 16), and 40 mg from week 17 onward, and the 60 mg dose is not recommended. For ages 16 to 17 years, the schedule starts at 2 mg (weeks 0 to 2), then 5 mg (weeks 3 to 6), 10 mg (weeks 7 to 10), 20 mg (weeks 11 to 14), and 40 mg from week 15 onward, and the 60 mg dose is not recommended.

For ages 18 years and older, the titration pattern is the same as for the 16 to 17 group, but a 60 mg dose is permitted after week 15. If a weak CYP3A4 inhibitor is started in a patient already on a stable lomitapide dosage, the lomitapide dose should be cut in half.

Cautious titration may afterward be considered, guided by LDL-C response and safety/tolerability, up to half of the maximum recommended dosage. The exception is coadministration with oral contraceptives alone, where the maximum recommended lomitapide dose is about two thirds of the usual maximum recommended dose.1

The Lomitapide and Estradiol Interaction, Explained

Estradiol may raise the amount of lomitapide in your body. Your body breaks down lomitapide using an enzyme called , and estrogen-type medicines like estradiol may slow that enzyme a little. This is based on theory rather than studies of these two drugs together. More lomitapide can mean more side effects, such as stomach upset, diarrhea, and liver problems.

Your care team can manage this by keeping your lomitapide dose within a lower maximum limit and checking how you respond. Keep taking both medicines as prescribed and talk with your pharmacist or doctor about any questions.

Mechanism: Estradiol (estrogens/oral contraceptive class) is a weak and may increase exposure to lomitapide, a CYP3A4 . Neither drug's activity depends on this pathway for activation. Evidence is theoretical; onset unspecified; severity on file is major.

  • Labeling caps lomitapide with oral contraceptives at 15 mg (2 to 10 y), 30 mg (11 to 17 y), and 40 mg (18 y and older).
  • Weak CYP3A4 inhibitor schedules are age-specific (for 18 y and older, 60 mg allowed after week 15 with weak in general).
  • If a weak inhibitor is started in a patient on stable lomitapide, reduce the dose by half, then titrate cautiously by LDL-C response and tolerability.
  • Monitor for adverse effects and per lomitapide monitoring.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Lomitapide and Estradiol Interact

The likely mechanism

of -mediated of lomitapide

In short: Estradiol slows CYP3A4, an enzyme that breaks down lomitapide, so lomitapide can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Lomitapide and Estradiol Interaction

Your care team typically manages this by adjusting and individualizing your lomitapide dose and monitoring you closely.

  • Your lomitapide dose may be capped at a lower maximum while you take estradiol, based on your age.
  • If you start estradiol while on a stable lomitapide dose, your prescriber may lower your dose and then increase it carefully, guided by your LDL cholesterol response and how well you tolerate it.
  • Keep taking both medicines as prescribed.
  • Tell your pharmacist or prescriber about any new stomach symptoms, diarrhea, or other concerns.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Lomitapide or Estradiol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

2 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: JUXTAPID oral capsules, lomitapide oral capsules

    Giving the combined oral contraceptive containing ethinylestradiol 0.035 mg and norgestimate 0.25 mg daily together with a single 20 mg dose of lomitapide was found to raise the of lomitapide by 30% and its by 40%, relative to lomitapide given alone.1

  2. Report 2 · Study title

    Prescribing information: JUXTAPID oral capsules, lomitapide oral capsules

    When atorvastatin (a weak ) 80 mg daily was given with a single 20 mg dose of lomitapide, the of lomitapide rose 2-fold and the rose 2.1-fold, compared with lomitapide given alone.1

Lomitapide and Estradiol: Common Questions

How serious is the Lomitapide and Estradiol interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Lomitapide and Estradiol interaction managed?

Your care team typically manages this by adjusting and individualizing your lomitapide dose and monitoring you closely. Your lomitapide dose may be capped at a lower maximum while you take estradiol, based on your age. If you start estradiol while on a stable lomitapide dose, your prescriber may lower your dose and then increase it carefully, guided by your LDL cholesterol response and how well yo… Management is individual — always follow your own care team's guidance.

Does taking Lomitapide and Estradiol at different times of day help?

No. Taking them at different times of day does not prevent this one. Estradiol slows , an enzyme that breaks down lomitapide, so lomitapide can build up in the body. That change lasts while estradiol is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

Who is at higher risk from the Lomitapide and Estradiol interaction?

The interaction record names this group as more likely to be affected:

  • People taking higher doses

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Lomitapide and Estradiol Interaction

Ask in your own words about taking Lomitapide and Estradiol together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: JUXTAPID® oral capsules, lomitapide oral capsules. Chiesi USA, Inc. (per Manufacturer), Cary, NC, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Lomitapide and Estradiol

Also serious with Lomitapide

Also serious with Estradiol

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Lomitapide

With Estradiol

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.